Clinical Trial Update: Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating doxorubicin in combination with dual checkpoint blockade for metastatic or advanced soft tissue sarcoma. The study is currently active …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Doxorubicin (doxorubicin)
• Dual checkpoint blockade (PD-1/PD-L1 and CTLA-4 inhibitors)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Metastatic Soft Tissue Sarcoma, Advanced Soft Tissue Sarcoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING